PortfoliosLab logoPortfoliosLab logo
THNR vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

THNR vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, THNR achieves a -5.67% return, which is significantly lower than XLVI's -0.67% return.


THNR

1D
-0.50%
1M
-3.61%
YTD
-5.67%
6M
-4.62%
1Y
8.57%
3Y*
5Y*
10Y*

XLVI

1D
0.67%
1M
2.30%
YTD
-0.67%
6M
0.76%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between THNR and XLVI is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.68

THNR vs. XLVI - Sectors Allocation Comparison


Sectors
THNR
XLVI

Healthcare

97.7%

-

Financial Services

0.9%
100.6%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

THNR
97.7%
XLVI

-

Financial Services

THNR
0.9%
XLVI
100.6%

Basic Materials

THNR

-

XLVI

-

Communication Services

THNR

-

XLVI

-

Consumer Cyclical

THNR

-

XLVI

-

Consumer Defensive

THNR

-

XLVI

-

Energy

THNR

-

XLVI

-

Industrials

THNR

-

XLVI

-

Real Estate

THNR

-

XLVI

-

Technology

THNR

-

XLVI

-

Utilities

THNR

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

THNR vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR
THNR Risk / Return Rank: 1717
Overall Rank
THNR Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
THNR Sortino Ratio Rank: 1717
Sortino Ratio Rank
THNR Omega Ratio Rank: 1616
Omega Ratio Rank
THNR Calmar Ratio Rank: 1818
Calmar Ratio Rank
THNR Martin Ratio Rank: 1717
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


THNRXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.09

Calmar ratioReturn relative to maximum drawdown

0.71

Martin ratioReturn relative to average drawdown

1.62

THNR vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


THNRXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.10

1.33

-1.43

Drawdowns

THNR vs. XLVI - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for THNR and XLVI.


Loading charts...

Drawdown Indicators


THNRXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-32.51%

-8.14%

-24.37%

Max Drawdown (1Y)

Largest decline over 1 year

-12.06%

Current Drawdown

Current decline from peak

-13.43%

-4.02%

-9.41%

Average Drawdown

Average peak-to-trough decline

-12.25%

-1.95%

-10.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.31%

Volatility

THNR vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


THNRXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.16%

Volatility (6M)

Calculated over the trailing 6-month period

13.37%

Volatility (1Y)

Calculated over the trailing 1-year period

19.16%

10.94%

+8.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.35%

10.94%

+8.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.35%

10.94%

+8.41%

THNR vs. XLVI - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

THNR vs. XLVI - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.74%, less than XLVI's 11.53% yield.


Frequently Asked Questions


THNR and XLVI have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.59% for THNR.

XLVI has the higher dividend yield at 11.53%, compared with 1.74% for THNR.

THNR is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Amplify and State Street. Their fees differ too: 0.59% for THNR and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for THNR and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer